MGRX vs NVS
Mangoceuticals, Inc. Common Stock (MGRX) versus NVS (NVS) — a side-by-side from cached financials, not a winner call.
Mangoceuticals, Inc. Common Stock (MGRX) is a health information services company listed on US.
NVS (NVS) common stock.
Latest reported MGRX revenue for 2025-12-31 was $456.0K. Net income was -$20.6M. Revenue was down 26.0% from 2024-12-31 to 2025-12-31. MGRX currently screens at market cap $16.3M.
NVS does not have a complete income-statement cache yet.
MGRX currently screens at market cap $16.3M. NVS currently screens at market cap $0.
Not investment advice. Open the MGRX and NVS stock pages for the full models.
Not investment advice.